Dynamic changes of serum hbv pgrna levels in patients with chronic hepatitis B treated with entecavir or peg-interferon

被引：1
|
作者：
Yu, Xiaoqi [1 ]
Yu, Demin [1 ]
Chen, Peizhan [2 ]
Gong, Qiming [3 ]
Zhang, Xinxin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Res Lab Clin Virol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Translat Med Res Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30963-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-218
引用
收藏
页码：E490 / E490
页数：1
相关论文
共 50 条
  • [11] Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load
    Jindal, Ankur
    Vyas, Ashish Kumar
    Sarin, Shiv Kumar
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (09): : 628 - 628
  • [12] CHRONIC PAIN IN HEPATITIS PATIENTS PRE AND POST PEG-INTERFERON TREATMENT
    Lallemant, Camille
    Greenwood, Matthew
    Muir, Jane
    Keller, Majella
    Tibble, Jerry
    Whale, Richard
    Haq, Inam
    RHEUMATOLOGY, 2010, 49 : I62 - I62
  • [13] In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection
    Sprengers, D.
    van der Molen, R. G.
    Binda, R.
    Kusters, J. G.
    de Man, R. A.
    Niesters, H. G. M.
    Schalm, S. W.
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 743 - 749
  • [14] Treatment of chronic hepatitis delta with PEG-interferon alpha-2b.
    Castelnau, C
    Gordien, E
    Boyer, N
    Martinot, M
    Deny, P
    Marcellin, P
    HEPATOLOGY, 2004, 40 (04) : 675A - 675A
  • [15] Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
    Seto, Wai-Kay
    Liu, Kevin S. H.
    Mak, Lung-Yi
    Cloherty, Gavin
    Wong, Danny Ka-Ho
    Gersch, Jeffrey
    Lam, Yuk-Fai
    Cheung, Ka-Shing
    Chow, Ning
    Ko, Kwan-Lung
    To, Wai-Pan
    Fung, James
    Yuen, Man-Fung
    GUT, 2021, 70 (04) : 775 - 783
  • [16] Treatment with PEG-interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Tan, Adriaan C.
    de Vries, Richard A.
    Adang, Rob
    Konings, Stijn
    Cnossen, Nynke
    Schalm, Solko W.
    van Leusen, Rob
    HEPATOLOGY, 2006, 44 (04) : 321A - 321A
  • [17] Comparative analysis of Peg-Interferon alpha-2b and lamivudine in the treatment of chronic hepatitis B patients
    Sidiropoulos, I
    Koliouskas, D
    Masmanidou, M
    Mandraveli, K
    Lazaraki, G
    Dokas, S
    Ziakas, A
    HEPATOLOGY, 2002, 36 (04) : 626A - 626A
  • [18] SERUM HBVRNA IS AN EARLY PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH PEG-INTERFERON ALPHA-2A (40kD)
    van Boemmel, F.
    van Boemmel, A.
    Krauel, A.
    He, H.
    Wat, C.
    Pavlovic, V.
    Deichsel, D.
    Berg, T.
    Boehm, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S560 - S561
  • [19] Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment
    Seto, Wai-Kay
    Lam, Yuk-Fai
    Fung, James
    Wong, Danny Ka-Ho
    Huang, Fung-Yu
    Hung, Ivan Fan-Ngai
    Lai, Ching-Lung
    Yuen, Man-Fung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (05) : 1028 - 1034
  • [20] Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B:: HBsAg loss is associated with HBV genotype
    Flink, HJ
    van Zonneveld, M
    Hansen, BE
    de Man, RA
    Schalm, SW
    Janssen, HLA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02): : 297 - 303
12345